Holen Sie sich die Stockscreener-App
0.7301
8.87%
-0.0711
Vorhandelsmarkt:
.75
0.0199
+2.73%
Schlusskurs vom Vortag:
$0.8012
Offen:
$0.781
24-Stunden-Volumen:
534.04K
Relative Volume:
1.80
Marktkapitalisierung:
$34.03M
Einnahmen:
$28,000
Nettoeinkommen (Verlust:
$-12.46M
KGV:
-1.9315
EPS:
-0.378
Netto-Cashflow:
$-11.18M
1W Leistung:
-13.02%
1M Leistung:
-17.10%
6M Leistung:
-20.93%
1J Leistung:
+14.24%
1-Tages-Spanne:
$0.7016
$0.8762
1-Wochen-Bereich:
$0.7016
$0.8762
52-Wochen-Spanne:
$0.38
$1.57
Talphera Inc Stock (TLPH) Company Profile
Firmenname
Talphera Inc
Sektor
Telefon
650-216-3500
Adresse
1850 GATEWAY DRIVE, SAN MATEO
Compare TLPH vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLPH
Talphera Inc
|
0.7301 | 34.03M | 28,000 | -12.46M | -11.18M | -0.378 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2020-07-20 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2019-11-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-04-24 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-02-15 | Eingeleitet | Credit Suisse | Outperform |
| 2018-10-23 | Eingeleitet | B. Riley FBR | Buy |
| 2017-10-13 | Herabstufung | Jefferies | Buy → Hold |
| 2017-10-13 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-07-14 | Fortgesetzt | Jefferies | Buy |
| 2016-09-15 | Bestätigt | ROTH Capital | Buy |
| 2016-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2015-10-30 | Hochstufung | Jefferies | Hold → Buy |
| 2015-10-05 | Bestätigt | ROTH Capital | Buy |
| 2015-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-07-10 | Fortgesetzt | ROTH Capital | Buy |
| 2015-05-06 | Bestätigt | Mizuho | Neutral |
| 2015-05-05 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-03-10 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-03-09 | Herabstufung | Mizuho | Buy → Neutral |
Alle ansehen
Talphera Inc Aktie (TLPH) Neueste Nachrichten
Talphera (TLPH) Reports Progress in Nafamostat Study and Financi - GuruFocus
Talphera: Q4 Earnings Snapshot - theheraldreview.com
Talphera, Inc. (Formerly AcelRx) 2025 Annual Report: Business Overview, Key Risks, and Regulatory Challenges in Specialty Pharmaceuticals - Minichart
Talphera Q4 2025 & Investor Day Earnings Call Transcript - MarketBeat
Talphera files prospectus for resale of up to 30.9M shares by selling stockholders - MSN
Talphera Inc. Q4 & Fiscal 2025 Financial Results: Revenue & Net Loss ReportNews and Statistics - IndexBox
[10-K] TALPHERA, INC. Files Annual Report - Stock Titan
Talphera 2025 10-K: Revenue $0.028M, Net Loss $14.3M - TradingView
TLPH: Net loss increased to $14.3M in 2025; urgent capital needs and Nasdaq delisting risk persist - TradingView
Earnings call transcript: Talphera Inc. Q4 2025: Stock Declines Amid Study Delays - Investing.com India
Talphera, Inc. (NASDAQ: TLPH) 2026 Financial Results and Company Information Overview - Minichart
Talphera, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Talphera Inc (TLPH) Reports Q4 Earnings - AlphaStreet
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Bitget
Talphera: Fourth Quarter Financial Results Overview - Bitget
Rate Hike: Can Talphera Inc grow without external fundingTake Profit & Comprehensive Market Scan Reports - baoquankhu1.vn
TLPH PE Ratio & Valuation, Is TLPH Overvalued - Intellectia AI
Talphera outlines accelerated NEPHRO CRRT study timeline with completion targeted by end of 2025, supported by new site activations and $14.8M financing - MSN
Street Watch: Can Talphera Inc keep up with sector leaders2026 Trends & Capital Efficiency Focused Strategies - baoquankhu1.vn
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 - ChartMill
Nantahala Capital-linked holders in Talphera (TLPH) acquire 4,266,211 pre-funded warrants - Stock Titan
Talphera, Inc. (formerly AcelRx Pharmaceuticals) Files Form 8-K – Company Details and SEC Filing Information - Minichart
Talphera (NASDAQ: TLPH) adds $4.1M in third private placement - Stock Titan
Talphera Receives Nasdaq Notice on Minimum Bid Price - The Globe and Mail
Talphera, Inc. 8-K SEC Filing: Company Information, Address, NASDAQ Listing & Key Details (March 11, 2026) - Minichart
Talphera Received Notice of Noncompliance - TradingView
Talphera (NASDAQ: TLPH) faces Nasdaq minimum bid-price deficiency notice - Stock Titan
Sentiment Recap: Can Talphera Inc grow without external funding2025 Big Picture & Weekly High Return Stock Opportunities - baoquankhu1.vn
Aug Sentiment: Is Talphera Inc a top pick in the sectorJuly 2025 Selloffs & Daily Profit Maximizing Tips - baoquankhu1.vn
Analysts’ Opinions Are Mixed on These Healthcare Stocks: CalciMedica (CALC) and Talphera (TLPH) - The Globe and Mail
TLPH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Talphera (TLPH) Achieves Key Enrollment Milestone in Clinical Tr - GuruFocus
Talphera reaches 50% enrollment in CRRT anticoagulant trial - Investing.com
Talphera announces 50% enrollment milestone in ongoing Nephro-Crrt registrational trial - marketscreener.com
Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial - TradingView
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial - marketscreener.com
Dow Update: What is Talphera Incs 5 year growth outlookMarket Growth Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Insider Buying: Talphera (NASDAQ:TLPH) Insider Acquires $28,350.00 in Stock - Defense World
Insider Buying: Talphera (NASDAQ:TLPH) CFO Buys $36,450.00 in Stock - Defense World
Talphera (NASDAQ:TLPH) Insider Purchases $28,350.00 in Stock - Defense World
Insider Buying: Talphera (NASDAQ:TLPH) CEO Purchases $85,344.84 in Stock - Defense World
Talphera CFO Asadorian buys $36k in TLPH stock By Investing.com - Investing.com South Africa
Aslam Shakil buys $28k in Talphera (TLPH) stock By Investing.com - Investing.com UK
Talphera (TLPH) CEO Angotti buys $85k in shares - Investing.com
Talphera (TLPH) CEO Angotti buys $85k in shares By Investing.com - Investing.com Australia
Talphera CFO Asadorian buys $36k in TLPH stock - Investing.com
Talphera’s Dasu Badri N buys $28,430 in shares - Investing.com Nigeria
Talphera’s Dasu Badri N buys $28,430 in shares By Investing.com - Investing.com Australia
Aslam Shakil buys $28k in Talphera (TLPH) stock - Investing.com
TALPHERA (TLPH) engineering chief buys 35K shares and receives 200K-option grant - Stock Titan
Rosalind Advisors, Inc. Expands Stake in Talphera Inc. - GuruFocus
Finanzdaten der Talphera Inc-Aktie (TLPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):